Brungart Douglas, Schurman Jaclyn, Konrad-Martin Dawn, Watts Kelly, Buckey Jay, Clavier Odile, Jacobs Peter G, Gordon Samuel, Dille Marilyn F
a Walter Reed National Military Medical Center , Bethesda , MD , USA.
b Army Public Hearing Center, Aberdeen Proving Ground , Aberdeen , MD , USA.
Int J Audiol. 2018 Sep;57(sup4):S25-S33. doi: 10.1080/14992027.2017.1370138. Epub 2017 Sep 12.
The goal of this article is to highlight mobile technology that is not yet standard of care but could be considered for use in an ototoxicity monitoring programme (OMP) as an adjunct to traditional audiometric testing. Current guidelines for ototoxicity monitoring include extensive test protocols performed by an audiologist in an audiometric booth. This approach is comprehensive, but it may be taxing for patients suffering from life-threatening illnesses and cost prohibitive if it requires serial clinical appointments. With the use of mobile technology, testing outside of the confines of the audiometric booth may be possible, which could create more efficient and less burdensome OMPs.
A non-systematic review of new OMP technology was performed. Experts were canvassed regarding the impact of new technology on OMPs.
OMP devices and technologies that are commercially available and discussed in the literature.
The benefits and limitations of portable, tablet-based technology that can be deployed for efficient ototoxicity monitoring are discussed.
New mobile technology has the potential to influence the development and implementation of OMPs and lower barriers to patient access by providing time efficient, portable and self-administered testing options for use in the clinic and in the patient's home.
本文旨在强调一种尚未成为标准治疗手段,但可在耳毒性监测计划(OMP)中作为传统听力测试辅助手段加以考虑的移动技术。当前耳毒性监测指南包括听力学家在听力测试室执行的广泛测试方案。这种方法很全面,但对于患有危及生命疾病的患者而言可能负担过重,而且如果需要进行系列临床预约,成本也过高。通过使用移动技术,在听力测试室范围之外进行测试或许可行,这可能会创建更高效且负担更小的耳毒性监测计划。
对新的耳毒性监测计划技术进行了非系统性综述。就新技术对耳毒性监测计划的影响向专家进行了咨询。
文献中讨论的市售耳毒性监测计划设备和技术。
讨论了可用于高效耳毒性监测的便携式平板技术的优缺点。
新的移动技术有可能影响耳毒性监测计划的开发与实施,并通过提供省时、便携且可自行操作的测试选项,用于临床及患者家中,从而降低患者接受监测的障碍。